ATA1292000A - Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen - Google Patents
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinenInfo
- Publication number
- ATA1292000A ATA1292000A AT0012900A AT1292000A ATA1292000A AT A1292000 A ATA1292000 A AT A1292000A AT 0012900 A AT0012900 A AT 0012900A AT 1292000 A AT1292000 A AT 1292000A AT A1292000 A ATA1292000 A AT A1292000A
- Authority
- AT
- Austria
- Prior art keywords
- immunulating
- pharmaceutical composition
- producing vaccines
- vaccines
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0012900A AT409085B (de) | 2000-01-28 | 2000-01-28 | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
ARP000106610A AR026940A1 (es) | 2000-01-28 | 2000-12-13 | Composicion farmaceuticas para modulacion inmunologica y preparacion de vacunas |
PCT/EP2001/000087 WO2001054720A1 (en) | 2000-01-28 | 2001-01-05 | Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
AT01903625T ATE392904T1 (de) | 2000-01-28 | 2001-01-05 | Pharmazeutische zusammensetzung zur immunstimulation und zur zubereitung von impfstoffen enthaltend ein antigen, und als adjuvantien ein immunogenes oligodesoxynukleotid und ein polykationisches polypeptid |
DE60133717T DE60133717T2 (de) | 2000-01-28 | 2001-01-05 | Pharmazeutische zusammensetzung zur immunstimulation und zur zubereitung von impfstoffen enthaltend ein antigen, und als adjuvantien ein immunogenes oligodesoxynukleotid und ein polykationisches polypeptid |
JP2001554703A JP2003520824A (ja) | 2000-01-28 | 2001-01-05 | 免疫変調用医薬組成物並びに抗原および免疫原性オリゴデオキシヌクレオチドおよびアジュバントとしてのポリカチオン性ポリマーを含むワクチンの調製 |
ES01903625T ES2304376T3 (es) | 2000-01-28 | 2001-01-05 | Composicion farmaceutica para la inmunomodulacion y preparacion de vacunas que comprenden un antigeno y, como adyuvantes, un oligodesoxinucleotido inmunogenico y un polpeptido policationico. |
EP01903625A EP1251871B1 (de) | 2000-01-28 | 2001-01-05 | Pharmazeutische zusammensetzung zur immunstimulation und zur zubereitung von impfstoffen enthaltend ein antigen, und als adjuvantien ein immunogenes oligodesoxynukleotid und ein polykationisches polypeptid |
AU31665/01A AU784403B2 (en) | 2000-01-28 | 2001-01-05 | Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
CA002396884A CA2396884A1 (en) | 2000-01-28 | 2001-01-05 | Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
UY26555A UY26555A1 (es) | 2000-01-28 | 2001-01-24 | Composición farmacéutica para modulación inmunológica y preparación de vacunas |
PE2001000093A PE20011217A1 (es) | 2000-01-28 | 2001-01-26 | Composicion farmaceutica para modulacion inmunologica y preparacion de vacunas |
US10/205,150 US20020197269A1 (en) | 2000-01-28 | 2002-07-25 | Pharmaceutical composition for immunomodulation and preparation of vaccines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0012900A AT409085B (de) | 2000-01-28 | 2000-01-28 | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA1292000A true ATA1292000A (de) | 2001-10-15 |
AT409085B AT409085B (de) | 2002-05-27 |
Family
ID=3635970
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0012900A AT409085B (de) | 2000-01-28 | 2000-01-28 | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
AT01903625T ATE392904T1 (de) | 2000-01-28 | 2001-01-05 | Pharmazeutische zusammensetzung zur immunstimulation und zur zubereitung von impfstoffen enthaltend ein antigen, und als adjuvantien ein immunogenes oligodesoxynukleotid und ein polykationisches polypeptid |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01903625T ATE392904T1 (de) | 2000-01-28 | 2001-01-05 | Pharmazeutische zusammensetzung zur immunstimulation und zur zubereitung von impfstoffen enthaltend ein antigen, und als adjuvantien ein immunogenes oligodesoxynukleotid und ein polykationisches polypeptid |
Country Status (12)
Country | Link |
---|---|
US (1) | US20020197269A1 (de) |
EP (1) | EP1251871B1 (de) |
JP (1) | JP2003520824A (de) |
AR (1) | AR026940A1 (de) |
AT (2) | AT409085B (de) |
AU (1) | AU784403B2 (de) |
CA (1) | CA2396884A1 (de) |
DE (1) | DE60133717T2 (de) |
ES (1) | ES2304376T3 (de) |
PE (1) | PE20011217A1 (de) |
UY (1) | UY26555A1 (de) |
WO (1) | WO2001054720A1 (de) |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6977245B2 (en) | 1999-04-12 | 2005-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
US20050226890A1 (en) * | 1999-08-12 | 2005-10-13 | Cohen David I | Tat-based vaccine compositions and methods of making and using same |
AU2001227889A1 (en) | 2000-01-14 | 2001-07-24 | The United States of America, represented by The Secretary, Department of Health & Human Services | Oligodeoxynucleotide and its use to induce an immune response |
US7129222B2 (en) | 2000-03-10 | 2006-10-31 | Dynavax Technologies Corporation | Immunomodulatory formulations and methods for use thereof |
US20030129251A1 (en) | 2000-03-10 | 2003-07-10 | Gary Van Nest | Biodegradable immunomodulatory formulations and methods for use thereof |
WO2006033665A1 (en) * | 2004-03-16 | 2006-03-30 | Inist Inc. | Tat-based vaccine compositions and methods of making and using same |
WO2005090392A1 (en) * | 2004-03-16 | 2005-09-29 | Inist Inc. | Tat-based tolerogen compositions and methods of making and using same |
CA2418854A1 (en) | 2000-08-17 | 2002-02-21 | Jorg Fritz | A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof |
CA2430691A1 (en) | 2000-12-27 | 2002-07-04 | Dynavax Technologies Corporation | Immunomodulatory polynucleotides and methods of using the same |
US20040081655A1 (en) * | 2001-01-05 | 2004-04-29 | Karen Lingnau | Methods and compositions comprising polycationic compounds |
CA2433794A1 (en) | 2001-01-05 | 2002-07-11 | Intercell Ag | Uses for polycationic compounds as vaccine adjuvants |
EP1404873B1 (de) | 2001-06-21 | 2013-05-22 | Dynavax Technologies Corporation | Chimäre immunmodulatorische verbindungen und verfahren zu deren verwendung |
US7666674B2 (en) | 2001-07-27 | 2010-02-23 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo |
AU2002326561B2 (en) | 2001-08-07 | 2008-04-03 | Dynavax Technologies Corporation | Immunomodulatory compositions, formulations, and methods for use thereof |
US7354909B2 (en) * | 2001-08-14 | 2008-04-08 | The United States Of America As Represented By Secretary Of The Department Of Health And Human Services | Method for rapid generation of mature dendritic cells |
CN1599623B (zh) | 2001-09-14 | 2011-05-11 | 赛托斯生物技术公司 | 免疫刺激物向病毒样颗粒内的包装:制备方法与用途 |
US20030134810A1 (en) * | 2001-10-09 | 2003-07-17 | Chris Springate | Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents |
WO2003094836A2 (en) * | 2001-10-12 | 2003-11-20 | University Of Iowa Research Foundation | Methods and products for enhancing immune responses using imidazoquinoline compounds |
US7615227B2 (en) | 2001-12-20 | 2009-11-10 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of CpG oligodeoxynucleotides to induce angiogenesis |
US8466116B2 (en) | 2001-12-20 | 2013-06-18 | The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of CpG oligodeoxynucleotides to induce epithelial cell growth |
US8088388B2 (en) | 2002-02-14 | 2012-01-03 | United Biomedical, Inc. | Stabilized synthetic immunogen delivery system |
AU2003242742B2 (en) * | 2002-06-20 | 2009-04-30 | Cytos Biotechnology Ag | Packaged virus-like particles for use as adjuvants: method of preparation and use |
US20040053880A1 (en) | 2002-07-03 | 2004-03-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US7807803B2 (en) | 2002-07-03 | 2010-10-05 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US8263091B2 (en) | 2002-09-18 | 2012-09-11 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides |
JP5116971B2 (ja) | 2002-10-15 | 2013-01-09 | インターセル アーゲー | B群連鎖球菌の接着因子をコードする核酸、b群連鎖球菌の接着因子、およびその使用 |
AU2003300919A1 (en) | 2002-12-11 | 2004-06-30 | Coley Pharmaceutical Gmbh | 5' cpg nucleic acids and methods of use |
US8158768B2 (en) | 2002-12-23 | 2012-04-17 | Dynavax Technologies Corporation | Immunostimulatory sequence oligonucleotides and methods of using the same |
PT1992635E (pt) | 2002-12-23 | 2012-03-20 | Dynavax Tech Corp | Oligonucleótidos de sequência imunoestimuladora e métodos de utilização dos mesmos |
US8193185B2 (en) | 2003-01-21 | 2012-06-05 | Novartis Vaccines And Diagnostics, Inc. | Use of tryptanthrin compounds for immune potentiation |
CN1756843B (zh) | 2003-03-04 | 2012-03-21 | 英特塞尔股份公司 | 化脓链球菌抗原 |
EP2345420B1 (de) * | 2003-03-24 | 2016-01-06 | Valneva Austria GmbH | Verwendung eines TH1-Immunantwort induzierenden Adjuvans zur Erhöhung der Immunantworten |
CA2520124A1 (en) | 2003-03-28 | 2004-10-14 | Chiron Corporation | Use of benzazole compounds for immunopotentiation |
AU2004226262A1 (en) | 2003-03-31 | 2004-10-14 | Intercell Ag | Staphylococcus epidermidis antigens |
EP2311988A1 (de) | 2003-04-15 | 2011-04-20 | Intercell AG | S. pneumoniae-Antigene |
WO2004099242A2 (en) | 2003-05-07 | 2004-11-18 | Intercell Ag | Streptococcus agalactiae antigens i + ii |
EP2267006A1 (de) | 2003-05-30 | 2010-12-29 | Intercell AG | Enterokokken-Antigene |
DE602004030343D1 (de) * | 2003-07-11 | 2011-01-13 | Intercell Ag | Hcv-vakzin |
WO2006002422A2 (en) | 2004-06-24 | 2006-01-05 | Novartis Vaccines And Diagnostics Inc. | Compounds for immunopotentiation |
WO2006115509A2 (en) | 2004-06-24 | 2006-11-02 | Novartis Vaccines And Diagnostics Inc. | Small molecule immunopotentiators and assays for their detection |
CA2615506A1 (en) | 2005-07-15 | 2007-01-25 | Novartis Ag | Pamps, pathogen associated molecular patterns |
JP5484732B2 (ja) | 2005-12-14 | 2014-05-07 | サイトス バイオテクノロジー アーゲー | 過敏症の治療のための免疫賦活性核酸パッケージ粒子 |
ES2427994T3 (es) | 2006-06-12 | 2013-11-05 | Cytos Biotechnology Ag | Procesos para empaquetar oligonucleótidos en partículas de tipo viral de bacteriófagos de ARN |
EP2292646A3 (de) | 2006-07-07 | 2011-06-08 | Intercell AG | Kleine Streptococcus-pyogenes-Antigene und Verwendung dafür |
JP2010503384A (ja) | 2006-09-15 | 2010-02-04 | インターセル アーゲー | ボレリア(Borrelia)抗原 |
EP1923069A1 (de) | 2006-11-20 | 2008-05-21 | Intercell AG | Schutzpeptide gegen S. pneumoniae und diesbezügliche Zusammensetzungen, Verfahren und Verwendungen |
AU2007333147B2 (en) | 2006-12-12 | 2013-12-19 | Kuros Us Llc | Oligonucleotides containing high concentrations of guanine monomers |
EP2120984A2 (de) | 2007-01-12 | 2009-11-25 | Intercell AG | Schützende proteine von s. agalactiae, kombinationen daraus und anwendungsverfahren dafür |
NZ599605A (en) | 2007-02-19 | 2013-11-29 | Marinepolymer Tech Inc | Hemostatic compositions and therapeutic regimens |
EP2497779A1 (de) | 2007-05-02 | 2012-09-12 | Intercell AG | Klebsiella-Antigene |
US20100203083A1 (en) | 2007-05-31 | 2010-08-12 | Medigene Ag | Mutated structural protein of a parvovirus |
EP2012122A1 (de) | 2007-07-06 | 2009-01-07 | Medigene AG | Strukturproteine von mutierten Parvoviren als Impfstoffe |
JP2010530229A (ja) | 2007-06-18 | 2010-09-09 | インターセル アーゲー | クラミジア属の抗原 |
WO2009030254A1 (en) | 2007-09-04 | 2009-03-12 | Curevac Gmbh | Complexes of rna and cationic peptides for transfection and for immunostimulation |
DE102007044093A1 (de) * | 2007-09-14 | 2009-03-19 | Phenion Gmbh & Co. Kg | Nukleinsäurehaltige kosmetische und/oder pharmazeutische Zubereitungen zur Induktion antimikrobieller Peptide in epithelialen Deckgeweben |
CN101977927A (zh) | 2008-03-17 | 2011-02-16 | 英特塞尔股份公司 | 针对肺炎链球菌保护的肽以及与其有关的组合物、方法和用途 |
NZ602945A (en) | 2008-06-27 | 2014-05-30 | Zoetis Llc | Novel adjuvant compositions |
US20100233270A1 (en) | 2009-01-08 | 2010-09-16 | Northwestern University | Delivery of Oligonucleotide-Functionalized Nanoparticles |
WO2010089340A2 (en) | 2009-02-05 | 2010-08-12 | Intercell Ag | Peptides protective against e. faecalis, methods and uses relating thereto |
US8617574B2 (en) | 2009-02-13 | 2013-12-31 | Valneva Austria Gmbh | Nontypable Haemophilus influenzae antigens |
CA2755897C (en) | 2009-03-23 | 2020-01-28 | Nanirx, Inc. | Treatment of cancers with immunostimulatory hiv tat derivative polypeptides |
US20110053829A1 (en) | 2009-09-03 | 2011-03-03 | Curevac Gmbh | Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
EP2308896A1 (de) | 2009-10-09 | 2011-04-13 | Sanofi-aventis | Polypeptides zum Binden an den Rezeptor für weiterentwickelte Glykierungsendprodukte sowie Zusammensetzungen und Verfahren, die diese Polypeptide beinhalten |
EP2319871A1 (de) | 2009-11-05 | 2011-05-11 | Sanofi-aventis | Polypeptide zum Binden an den Rezeptor für weiterentwickelte Glykierungsendprodukte sowie Zusammensetzungen und Verfahren, die diese Polypeptide beinhalten |
WO2011042548A1 (en) | 2009-10-09 | 2011-04-14 | Sanofi-Aventis | Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
EP2575876B1 (de) | 2010-05-26 | 2017-12-06 | Selecta Biosciences, Inc. | Multivalente synthetische nanoträger-impfstoffe |
US9598472B2 (en) | 2010-09-03 | 2017-03-21 | Valneva Austria Gmbh | Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereof |
AR082925A1 (es) | 2010-09-08 | 2013-01-16 | Medigene Ag | Proteinas estructurales mutadas por parvovirus con epitopo de celulas b de proteccion cruzada, producto y metodos relacionados |
US9441013B2 (en) | 2011-05-17 | 2016-09-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanocortin 1 receptor ligands and methods of use |
MX2014001142A (es) | 2011-07-29 | 2014-02-27 | Selecta Biosciences Inc | Nanoportadores sinteticos que generan respuestas inmunitarias humorales y de linfocitos t citotoxicos (ctl). |
EP3838294A1 (de) * | 2012-01-31 | 2021-06-23 | CureVac AG | Negativ geladene nukleinsäure mit komplexen zur immunstimulation |
WO2013113326A1 (en) * | 2012-01-31 | 2013-08-08 | Curevac Gmbh | Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen |
WO2013113325A1 (en) * | 2012-01-31 | 2013-08-08 | Curevac Gmbh | Negatively charged nucleic acid comprising complexes for immunostimulation |
CN105579582A (zh) | 2013-07-25 | 2016-05-11 | 埃克西奎雷股份有限公司 | 用于预防和治疗用途的作为免疫刺激剂的基于球形核酸的构建体 |
BR112016003361A2 (pt) | 2013-08-21 | 2017-11-21 | Curevac Ag | vacina do vírus sincicial respiratório (rsv) |
CN109675026A (zh) | 2013-09-19 | 2019-04-26 | 硕腾服务有限责任公司 | 油基佐剂 |
AU2014329393B2 (en) | 2013-10-04 | 2020-04-30 | Pin Pharma, Inc. | Immunostimulatory HIV Tat derivative polypeptides for use in cancer treatment |
WO2015149944A2 (en) | 2014-04-01 | 2015-10-08 | Curevac Gmbh | Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant |
EP3164113B1 (de) | 2014-06-04 | 2019-03-27 | Exicure, Inc. | Multivalente freisetzung von immunmodulatoren durch liposomale sphärische nukleinsäuren für prophylaktische oder therapeutische anwendungen |
JP2017537619A (ja) | 2014-11-21 | 2017-12-21 | ノースウェスタン ユニバーシティ | 球状核酸ナノ粒子複合体の配列特異的細胞内取込 |
SI3244920T1 (sl) | 2015-01-16 | 2023-09-29 | The United States of America, represented by The Secretary of Agriculture, United States Department of Agriculture | Cepivo proti slinavki in parkljevki |
US11364304B2 (en) | 2016-08-25 | 2022-06-21 | Northwestern University | Crosslinked micellar spherical nucleic acids |
US11696954B2 (en) | 2017-04-28 | 2023-07-11 | Exicure Operating Company | Synthesis of spherical nucleic acids using lipophilic moieties |
AU2019220386A1 (en) | 2018-02-16 | 2020-08-20 | 2A Pharma Ab | Parvovirus structural protein for the treatment of autoimmune diseases |
EP3527223A1 (de) | 2018-02-16 | 2019-08-21 | 2A Pharma AB | Mutiertes parvovirus-strukturprotein |
CA3138064A1 (en) | 2019-05-20 | 2020-11-26 | Valneva Se | A subunit vaccine for treatment or prevention of a respiratory tract infection |
WO2023083964A1 (en) | 2021-11-11 | 2023-05-19 | 2A Pharma Ab | Parvovirus structural protein against beta- and gamma-hpv |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ221306A (en) * | 1986-08-15 | 1990-02-26 | Commw Scient Ind Res Org | 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof |
ATE420171T1 (de) * | 1994-07-15 | 2009-01-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
CO4600681A1 (es) * | 1996-02-24 | 1998-05-08 | Boehringer Ingelheim Pharma | Composicion farmaceutica para la modulacion inmunitaria |
ATE292980T1 (de) * | 1996-10-11 | 2005-04-15 | Univ California | Immunostimulierende oligonucleotidekonjugate |
CA2289741A1 (en) * | 1997-05-19 | 1998-11-26 | Merck & Co., Inc. | Oligonucleotide adjuvant |
US6589940B1 (en) * | 1997-06-06 | 2003-07-08 | Dynavax Technologies Corporation | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
DE19803453A1 (de) * | 1998-01-30 | 1999-08-12 | Boehringer Ingelheim Int | Vakzine |
-
2000
- 2000-01-28 AT AT0012900A patent/AT409085B/de not_active IP Right Cessation
- 2000-12-13 AR ARP000106610A patent/AR026940A1/es unknown
-
2001
- 2001-01-05 AT AT01903625T patent/ATE392904T1/de not_active IP Right Cessation
- 2001-01-05 CA CA002396884A patent/CA2396884A1/en not_active Abandoned
- 2001-01-05 WO PCT/EP2001/000087 patent/WO2001054720A1/en active IP Right Grant
- 2001-01-05 JP JP2001554703A patent/JP2003520824A/ja not_active Withdrawn
- 2001-01-05 ES ES01903625T patent/ES2304376T3/es not_active Expired - Lifetime
- 2001-01-05 AU AU31665/01A patent/AU784403B2/en not_active Ceased
- 2001-01-05 EP EP01903625A patent/EP1251871B1/de not_active Expired - Lifetime
- 2001-01-05 DE DE60133717T patent/DE60133717T2/de not_active Expired - Lifetime
- 2001-01-24 UY UY26555A patent/UY26555A1/es unknown
- 2001-01-26 PE PE2001000093A patent/PE20011217A1/es not_active Application Discontinuation
-
2002
- 2002-07-25 US US10/205,150 patent/US20020197269A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1251871A1 (de) | 2002-10-30 |
ES2304376T3 (es) | 2008-10-16 |
ATE392904T1 (de) | 2008-05-15 |
DE60133717D1 (de) | 2008-06-05 |
UY26555A1 (es) | 2001-08-27 |
JP2003520824A (ja) | 2003-07-08 |
AR026940A1 (es) | 2003-03-05 |
DE60133717T2 (de) | 2009-07-02 |
US20020197269A1 (en) | 2002-12-26 |
AT409085B (de) | 2002-05-27 |
CA2396884A1 (en) | 2001-08-02 |
AU784403B2 (en) | 2006-03-30 |
WO2001054720A1 (en) | 2001-08-02 |
AU3166501A (en) | 2001-08-07 |
PE20011217A1 (es) | 2001-12-04 |
EP1251871B1 (de) | 2008-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA1292000A (de) | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen | |
ATE468324T1 (de) | Pharmazeutische zusammensetzung | |
DE60138495D1 (de) | Pharmazeutische Zusammensetzung Trehalose zur ophthalmischen Verwendung enthaltend | |
EE200300145A (et) | Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon | |
ATE292960T1 (de) | Pharmazeutische zubereitung zur anwendung in der antiasthmatherapie | |
DE60106623D1 (de) | Neue pharmazeutische zusammensetzung | |
DE60041782D1 (de) | Bioaktiver und osteoporotischer knochenzement | |
DE60126321D1 (de) | Gelsystem zur ocularen verabreichung von arzneimitteln | |
ATE361058T1 (de) | Tablette und verfahren zur herstellung derselben | |
EE05149B1 (et) | Biarlkarboksamiidid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis | |
ATE280583T1 (de) | Stabilisierte pharmazeutische zusammentsetzung in lyophilisierter form | |
DE60131760D1 (de) | Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform | |
AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
EE05020B1 (et) | Glburiidi ravimkoostis | |
ATE293978T1 (de) | Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung | |
ATE522203T1 (de) | Pharmazeutische herstellung zur bindung von acetaldehyd in speichel, magen und dickdarm | |
DE60120416D1 (de) | Polyaminoestern und deren verwendung zur herstellung von dentalmassen | |
DE60211183D1 (de) | Pharmazeutische zusammensetzung enthaltend lumiracoxib | |
DE60119354D1 (de) | Spritze zur Dentalanästhesie | |
DE60203178D1 (de) | Pharmazeutische formulierung mit überdecktem geschmack und verfahren zu ihrer herstellung | |
DE60129238D1 (de) | Pharmazeutische zusammensetzung | |
DE60217390D1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
ATA90422002A (de) | Neues hydroxyliertes 3-phenoxy-3-phenyl-1- aminopropan und dieses aminopropan enthaltende pharmazeutische formulierung | |
DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
ATE439855T1 (de) | Transformierender wachstumsfaktor alpha enthaltende impfstoffzusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Change of the owner |
Owner name: INTERCELL AG, AT Effective date: 20120919 |
|
MM01 | Lapse because of not paying annual fees |
Effective date: 20121015 |